| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Lymphocyte-specific protein 1;47 kDa actin-binding protein;52 kDa phosphoprotein;pp52;Lymphocyte-specific antigen WP34;LSP1;WP34; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Host | |
| Immunogen | A synthesized peptide derived from human ING1 |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-ING1 Rabbit Monoclonal Antibody catalog # M02999. Tested in WB application. This antibody reacts with Human, Mouse, Rat.
Protein: T-cell surface glycoprotein CD3 zeta chain | Gene: Lymphocyte-specific protein 1 | Target: ING1 | Function: May play a role in mediating neutrophil activation and chemotaxis. . | Research areas: Adaptive Immunity,Calcium Binding Proteins,Calcium Signaling,Immunology,Non-CD,Signal Transduction,Signaling Pathway,T Cells
Host: Rabbit | Clonality/Clone: Monoclonal / Clone: 28I93 | Isotype: IgG | Reactivity: Human,Mouse,Rat | Immunogen: A synthesized peptide derived from human ING1 | Concentration: 0.5mg/ml | Purification: Affinity-chromatography
Applications: WB
Observed MW: 47 kDa | Calculated MW: 37192 MW
Cellular localization: Cell membrane; Peripheral membrane protein; Cytoplasmic side.
Tissue details: Activated T-lymphocytes.
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
